This issue brief examines how the Trump Administration proposals to lower drug costs described in the Administration’s Blueprint affect Medicaid. These include proposals to change the Medicaid Drug Rebate Program, as well as other approaches.
This issue brief examines how the Trump Administration proposals to lower drug costs described in the Administration’s Blueprint affect Medicaid. These include proposals to change the Medicaid Drug Rebate Program, as well as other approaches.